275 related articles for article (PubMed ID: 20179208)
1. Cyclin D1/cyclin-dependent kinase 4 interacts with filamin A and affects the migration and invasion potential of breast cancer cells.
Zhong Z; Yeow WS; Zou C; Wassell R; Wang C; Pestell RG; Quong JN; Quong AA
Cancer Res; 2010 Mar; 70(5):2105-14. PubMed ID: 20179208
[TBL] [Abstract][Full Text] [Related]
2. Filamin A regulates focal adhesion disassembly and suppresses breast cancer cell migration and invasion.
Xu Y; Bismar TA; Su J; Xu B; Kristiansen G; Varga Z; Teng L; Ingber DE; Mammoto A; Kumar R; Alaoui-Jamali MA
J Exp Med; 2010 Oct; 207(11):2421-37. PubMed ID: 20937704
[TBL] [Abstract][Full Text] [Related]
3. Growth inhibition of human MDA-mB-231 breast cancer cells by delta-tocotrienol is associated with loss of cyclin D1/CDK4 expression and accompanying changes in the state of phosphorylation of the retinoblastoma tumor suppressor gene product.
Elangovan S; Hsieh TC; Wu JM
Anticancer Res; 2008; 28(5A):2641-7. PubMed ID: 19035289
[TBL] [Abstract][Full Text] [Related]
4. Adapter protein SH2B1beta binds filamin A to regulate prolactin-dependent cytoskeletal reorganization and cell motility.
Rider L; Diakonova M
Mol Endocrinol; 2011 Jul; 25(7):1231-43. PubMed ID: 21566085
[TBL] [Abstract][Full Text] [Related]
5. Ribociclib (LEE011) suppresses cell proliferation and induces apoptosis of MDA-MB-231 by inhibiting CDK4/6-cyclin D-Rb-E2F pathway.
Li T; Xiong Y; Wang Q; Chen F; Zeng Y; Yu X; Wang Y; Zhou F; Zhou Y
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4001-4011. PubMed ID: 31588803
[TBL] [Abstract][Full Text] [Related]
6. Ribosomal S6 kinase (RSK) regulates phosphorylation of filamin A on an important regulatory site.
Woo MS; Ohta Y; Rabinovitz I; Stossel TP; Blenis J
Mol Cell Biol; 2004 Apr; 24(7):3025-35. PubMed ID: 15024089
[TBL] [Abstract][Full Text] [Related]
7. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
[TBL] [Abstract][Full Text] [Related]
8. Bisphenol S promotes the cell cycle progression and cell proliferation through ERα-cyclin D-CDK4/6-pRb pathway in MCF-7 breast cancer cells.
Lin Z; Zhang X; Zhao F; Ru S
Toxicol Appl Pharmacol; 2019 Mar; 366():75-82. PubMed ID: 30684532
[TBL] [Abstract][Full Text] [Related]
9. Fangchinoline induces G1 arrest in breast cancer cells through cell-cycle regulation.
Xing Z; Zhang Y; Zhang X; Yang Y; Ma Y; Pang D
Phytother Res; 2013 Dec; 27(12):1790-4. PubMed ID: 23401195
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor (EGF) regulates α5β1 integrin activation state in human cancer cell lines through the p90RSK-dependent phosphorylation of filamin A.
Vial D; McKeown-Longo PJ
J Biol Chem; 2012 Nov; 287(48):40371-80. PubMed ID: 23007402
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle regulators cyclin D1 and CDK4/6 have estrogen receptor-dependent divergent functions in breast cancer migration and stem cell-like activity.
Lamb R; Lehn S; Rogerson L; Clarke RB; Landberg G
Cell Cycle; 2013 Aug; 12(15):2384-94. PubMed ID: 23839043
[TBL] [Abstract][Full Text] [Related]
12. The cyclin D1-CDK4 oncogenic interactome enables identification of potential novel oncogenes and clinical prognosis.
Jirawatnotai S; Sharma S; Michowski W; Suktitipat B; Geng Y; Quackenbush J; Elias JE; Gygi SP; Wang YE; Sicinski P
Cell Cycle; 2014; 13(18):2889-900. PubMed ID: 25486477
[TBL] [Abstract][Full Text] [Related]
13. Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression.
Grillo M; Bott MJ; Khandke N; McGinnis JP; Miranda M; Meyyappan M; Rosfjord EC; Rabindran SK
Breast Cancer Res Treat; 2006 Jan; 95(2):185-94. PubMed ID: 16319987
[TBL] [Abstract][Full Text] [Related]
14. Negative regulation of TSC1-TSC2 by mammalian D-type cyclins.
Zacharek SJ; Xiong Y; Shumway SD
Cancer Res; 2005 Dec; 65(24):11354-60. PubMed ID: 16357142
[TBL] [Abstract][Full Text] [Related]
15. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells.
Bindels EM; Lallemand F; Balkenende A; Verwoerd D; Michalides R
Oncogene; 2002 Nov; 21(53):8158-65. PubMed ID: 12444551
[TBL] [Abstract][Full Text] [Related]
16. Functional consequences of cyclin D1/BRCA1 interaction in breast cancer cells.
Kehn K; Berro R; Alhaj A; Bottazzi ME; Yeh WI; Klase Z; Van Duyne R; Fu S; Kashanchi F
Oncogene; 2007 Aug; 26(35):5060-9. PubMed ID: 17334399
[TBL] [Abstract][Full Text] [Related]
17. Location, location, location: the role of cyclin D1 nuclear localization in cancer.
Gladden AB; Diehl JA
J Cell Biochem; 2005 Dec; 96(5):906-13. PubMed ID: 16163738
[TBL] [Abstract][Full Text] [Related]
18. Filamin A controls matrix metalloproteinase activity and regulates cell invasion in human fibrosarcoma cells.
Baldassarre M; Razinia Z; Brahme NN; Buccione R; Calderwood DA
J Cell Sci; 2012 Aug; 125(Pt 16):3858-69. PubMed ID: 22595522
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor binding protein-3 induces G1 cell cycle arrest with inhibition of cyclin-dependent kinase 2 and 4 in MCF-7 human breast cancer cells.
Kim HS; Lee WJ; Lee SW; Chae HW; Kim DH; Oh Y
Horm Metab Res; 2010 Mar; 42(3):165-72. PubMed ID: 19960406
[TBL] [Abstract][Full Text] [Related]
20. Integrin-binding protein nischarin interacts with tumor suppressor liver kinase B1 (LKB1) to regulate cell migration of breast epithelial cells.
Jain P; Baranwal S; Dong S; Struckhoff AP; Worthylake RA; Alahari SK
J Biol Chem; 2013 May; 288(22):15495-509. PubMed ID: 23572524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
